Scoping Review: Analysis Of Drug-Related Problems In Geriatric Patients With End-Stage Renal Disease
DOI:
https://doi.org/10.31941/benzena.v5i01.7861Keywords:
Keywords: CKD advanced, Drug related problems, Aging, Polypharmacy, Cardiovascular diseaseAbstract
Backgrounds: Chronic Kidney Disease decreases the glomerular filtration rate eGFR <60 ml/minute/1.73 m2 for three months. CKD can cause renal dysfunction, end-stage renal disease, and progression of cardiovascular disease. The increasing prevalence of chronic kidney disease(CKD) affects aging populations. The Elderly frequently present multiple comorbidities leading to polypharmacy and are vulnerable to medication-related problems.
Objective: This study aimed to review potential drug-related problems (DRPs) in geriatric patients with advanced CKD.
Methods: The research approach is a scoping review, which involves searching for publications published in journals about drug-related difficulties in geriatric patients or elderly with ESRD. Literature searches were conducted through electronic database searches, including PubMed, Science Direct, and Google Scholar. Journals were selected based on inclusion criteria and exclusion criteria.
Results: The results led to 5 published journals that indicate DRPs in CKD patients statistically increase along with age due to comorbidities and polypharmacy.
Conclusion: The most common DRPs found were inappropriate medication, side effects, non-prescribed drugs, contraindications, and medication prescribing errors. Healthcare providers must reassess each medication prescribed for every elderly patient to minimize the incidence of DRPs.
Downloads
References
Arcoraci, V., Barbieri, M. A., Rottura, M., Nobili, A., Natoli, G., Argano, C., Squadrito, G., Squadrito, F., & Corrao, S. (2021). Kidney disease management in the hospital setting: A focus on inappropriate drug prescriptions in older patients. Frontiers in Pharmacology, 12(October), 1–10. https://doi.org/10.3389/fphar.2021.749711
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., Ahmadian, E., Al-Aly, Z., Alipour, V., Almasi-Hashiani, A., Al-Raddadi, R. M., Alvis-Guzman, N., Amini, S., Andrei, T., Andrei, C. L., … Murray, C. J. L. (2020). Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 395(10225), 709–733. https://doi.org/10.1016/S0140-6736(20)30045-3
Garedow, A. W., Mulisa Bobasa, E., Desalegn Wolide, A., Kerga Dibaba, F., Gashe Fufa, F., Idilu Tufa, B., Debalke, S., & Kumela Goro, K. (2019). Drug-Related Problems and Associated Factors among Patients Admitted with Chronic Kidney Disease at Jimma University Medical Center, Jimma Zone, Jimma, Southwest Ethiopia: A Hospital-Based Prospective Observational Study. International Journal of Nephrology, 2019, 1504371. https://doi.org/10.1155/2019/1504371
Gayathri, B., Gayathri, B., Divasish, L., … M. S.-I. J. P., & 2018, U. (2018). Drug related problems: A systemic literature review. IAJPS, 5(3), 1409–1414. https://doi.org/10.5281/zenodo.1198191
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, F. D. R. (2016). Global prevalence of chronic kidney disease—A systematic review and meta-analysis. PLoS ONE, 11(7), 1–18. https://doi.org/10.1371/journal.pone.0158765
KDIGO. (2013). Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group., Kidney Int(1), 1–163. https://doi.org/10.1038/ki.2013.243
Kemenkes RI. (2017). InfoDATIN. Pusat Data dan Informasi Kementrian Kesehatan RI : Situasi penyakit ginjal kronik.
Kemenkes RI. (2018). Riset Kesehatan Dasar Riskesdas 2018. Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI. In Badan Penelitian dan Pengembangan Kesehatan (pp. 1–674).
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4S), S117–S314. https://doi.org/10.1016/j.kint.2023.10.018
Kim, A. J., Lee, H., Shin, E.-J., Cho, E.-J., Cho, Y. S., Lee, H., & Lee, J.-Y. (2021). Pharmacist-led collaborative medication management for the elderly with chronic kidney disease and polypharmacy. International Journal of Environmental Research and Public Health, 18(8). https://doi.org/10.3390/ijerph18084370
Quintana-Bárcena, P., Lord, A., Lizotte, A., Berbiche, D., & Lalonde, L. (2018). Prevalence and management of drug-related problems in chronic kidney disease patients by severity level: A subanalysis of a cluster randomized controlled trial in community pharmacies. Journal of Managed Care & Specialty Pharmacy, 24(2), 173–181. https://doi.org/10.18553/jmcp.2018.24.2.173
Roux-Marson, C., Baranski, J. B., Fafin, C., Exterman, G., Vigneau, C., Couchoud, C., Moranne, O., & Investigators, P. S. P. A. (2020). Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease. BMC Geriatrics, 20(1), 87. https://doi.org/10.1186/s12877-020-1485-4
van Berlo-van de Laar, I. R. F., Sluiter, H. E., Riet, E. van ’t, Taxis, K., & Jansman, F. G. A. (2020). Pharmacist-led medication reviews in pre-dialysis and dialysis patients. Research in Social and Administrative Pharmacy, 16(12), 1718–1723. https://doi.org/10.1016/j.sapharm.2020.02.006
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Kharina Anisya, Fita Rahmawati
This work is licensed under a Creative Commons Attribution 4.0 International License.
uthors who publish with BENZENA Pharmaceutical Scientific Journal agree to the following terms:- Authors retain copyright and grant the BENZENA Pharmaceutical Scientific Journal right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
